Artiva Biotherapeutics, Inc.
ARTV
$2.88
$0.113.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.13M | -71.72M | -65.37M | -61.28M | -32.53M |
| Total Depreciation and Amortization | 2.51M | 2.47M | 2.43M | 2.41M | 2.34M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.74M | 8.26M | 8.24M | 8.91M | 7.90M |
| Change in Net Operating Assets | -2.20M | 1.20M | -325.00K | -1.10M | -27.91M |
| Cash from Operations | -69.09M | -59.79M | -55.03M | -51.06M | -50.19M |
| Capital Expenditure | -1.73M | -1.14M | -642.00K | -1.21M | -1.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.78M | -119.14M | -119.82M | -120.95M | 9.27M |
| Cash from Investing | -100.50M | -120.27M | -120.46M | -122.17M | 7.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -137.00K | -182.00K | -149.00K | -116.00K | -78.00K |
| Issuance of Common Stock | 166.67M | 166.70M | 166.56M | 166.54M | 22.00K |
| Repurchase of Common Stock | -39.00K | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.49M | -4.05M | -4.18M | -3.20M | 22.83M |
| Cash from Financing | 164.01M | 162.47M | 162.23M | 163.22M | 22.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.58M | -17.60M | -13.27M | -10.00M | -19.45M |